Zobrazeno 1 - 4
of 4
pro vyhledávání: '"David Guillen-Carbajal"'
Autor:
José Salvador-Carrillo MSc, Luz Campos-Loza MD, David Guillen-Carbajal MD, Jakelyn Real-Pantoja MD, Allison Pachas MSEd, Diego Crisol-Deza MD, Luis Saravia MPH, Oliver Rey-Vidal BSc, Luis Usquiano-Cardenas MBM, Claudio Flores PhD, Víctor Izaguirre MSc, Alejandra Zevallos MSc, Williams Fajardo MPH
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 61 (2024)
The COVID-19 pandemic has led many people to turn to self-medication as an accessible and convenient method of managing their health. Thus, this study sought to describe the self-medication practices (SMP) and their risk factors among the Peruvian po
Externí odkaz:
https://doaj.org/article/a411f2d9d9d7405d9b05bb6b947fd430
Autor:
David Guillen-Carbajal, Luz Campos-Loza, J. Smith Torres-Roman, Jose Salvador-Carrillo, Jorge Osada, Alejandra Zevallos
Publikováno v:
F1000Research, Vol 12 (2024)
Background Peru has reported one of the highest mortality rates from COVID-19 worldwide. The Chincha province has been one of the most affected regions in Peru and the leading promoter of the use of ivermectin for the treatment of COVID-19. Therefore
Externí odkaz:
https://doaj.org/article/5ee6cb3ff4244d339bb9c6c9720bdcdd
Autor:
David Guillen-Carbajal, Luz Campos-Loza, J. Smith Torres-Roman, Jose Salvador-Carrillo, Jorge Osada, Alejandra Zevallos
Publikováno v:
F1000Research, Vol 12 (2023)
Background: Peru has reported one of the highest mortality rates by COVID-19 worldwide. The Chincha province has been one of the most affected regions in Peru and the leading promoter of the use of ivermectin for the treatment of COVID-19. Therefore,
Externí odkaz:
https://doaj.org/article/2eb6084d70cd4ba489a23d223ce66cd5
Autor:
Jose Salvador-Carrillo, Luz Campos-Loza, David Guillen-Carbajal, Jorge Osada, Alejandra Zevallos, J. Smith Torres-Roman
Publikováno v:
F1000Research. 12:149
Background: Peru has reported one of the highest mortality rates from COVID-19 worldwide. The Chincha province has been one of the most affected regions in Peru and the leading promoter of the use of ivermectin for the treatment of COVID-19. Therefor